Variant report

Variant	esv3502183
Chromosome Location	chr11:58668353-58731177
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:58693760-58694429	HepG2	liver:	n/a	n/a
2	ARID3A	chr11:58713222-58713481	HepG2	liver:	n/a	n/a
3	ATF1	chr11:58691061-58691064	K562	blood:	n/a	n/a
4	ATF2	chr11:58694851-58695251	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr11:58672951-58673767	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr11:58690792-58691378	H1-hESC	embryonic stem cell:	n/a	n/a
7	BHLHE40	chr11:58668390-58668584	HepG2	liver:	n/a	n/a
8	BHLHE40	chr11:58693810-58694128	HepG2	liver:	n/a	n/a
9	BHLHE40	chr11:58673515-58673655	K562	blood:	n/a	n/a
10	BHLHE40	chr11:58668343-58668597	K562	blood:	n/a	n/a
11	BRCA1	chr11:58673350-58673665	H1-hESC	embryonic stem cell:	n/a	n/a
12	CBX3	chr11:58684602-58685036	HCT-116	colon:	n/a	n/a
13	CBX3	chr11:58684635-58685102	HCT-116	colon:	n/a	n/a
14	CBX3	chr11:58684666-58684899	K562	blood:	n/a	n/a
15	CEBPB	chr11:58693679-58694509	IMR90	lung:	n/a	chr11:58694316-58694329
16	CEBPB	chr11:58693768-58694393	HepG2	liver:	n/a	chr11:58694316-58694329
17	CEBPB	chr11:58719355-58719662	K562	blood:	n/a	chr11:58719485-58719496 chr11:58719485-58719498 chr11:58719487-58719498 chr11:58719485-58719498
18	CEBPB	chr11:58695605-58695843	HepG2	liver:	n/a	chr11:58695719-58695730
19	CEBPB	chr11:58719387-58719568	H1-hESC	embryonic stem cell:	n/a	chr11:58719485-58719496 chr11:58719485-58719498 chr11:58719487-58719498 chr11:58719485-58719498
20	CEBPB	chr11:58713178-58713528	HepG2	liver:	n/a	chr11:58713351-58713364
21	CEBPB	chr11:58713294-58713398	HepG2	liver:	n/a	chr11:58713351-58713364
22	CEBPB	chr11:58719356-58719620	HepG2	liver:	n/a	chr11:58719485-58719496 chr11:58719485-58719498 chr11:58719487-58719498 chr11:58719485-58719498
23	CEBPB	chr11:58713691-58713878	IMR90	lung:	n/a	n/a
24	CEBPB	chr11:58719316-58719632	IMR90	lung:	n/a	chr11:58719485-58719496 chr11:58719485-58719498 chr11:58719487-58719498 chr11:58719485-58719498
25	CEBPB	chr11:58719331-58719581	A549	lung:	n/a	chr11:58719485-58719496 chr11:58719485-58719498 chr11:58719487-58719498 chr11:58719485-58719498
26	CHD1	chr11:58672850-58673135	H1-hESC	embryonic stem cell:	n/a	n/a
27	CHD1	chr11:58672403-58673216	IMR90	lung:	n/a	n/a
28	CHD2	chr11:58668301-58668501	GM12878	blood:	n/a	n/a
29	CHD2	chr11:58668323-58668505	K562	blood:	n/a	n/a
30	CHD2	chr11:58730953-58731524	H1-hESC	embryonic stem cell:	n/a	n/a
31	CHD2	chr11:58668027-58668642	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD2	chr11:58694884-58695809	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD2	chr11:58672662-58673757	H1-hESC	embryonic stem cell:	n/a	n/a
34	CREB1	chr11:58725448-58725809	GM12878	blood:	n/a	n/a
35	CREB1	chr11:58668219-58668775	H1-hESC	embryonic stem cell:	n/a	n/a
36	CREB1	chr11:58668271-58668693	H1-hESC	embryonic stem cell:	n/a	n/a
37	CREB1	chr11:58725455-58725792	GM12878	blood:	n/a	n/a
38	CTCF	chr11:58725952-58726268	K562	blood:	n/a	chr11:58726167-58726185 chr11:58726168-58726184 chr11:58726169-58726190 chr11:58726170-58726183 chr11:58726170-58726179
39	CTCF	chr11:58668359-58668567	GM10248	blood:	n/a	chr11:58668444-58668457 chr11:58668442-58668460 chr11:58668437-58668458
40	CTCF	chr11:58725997-58726354	K562	blood:	n/a	chr11:58726167-58726185 chr11:58726168-58726184 chr11:58726169-58726190 chr11:58726170-58726183 chr11:58726170-58726179
41	CTCF	chr11:58673020-58673170	HEK293	kidney:	n/a	n/a
42	CTCF	chr11:58668400-58668550	AG09309	skin:	n/a	chr11:58668444-58668457 chr11:58668442-58668460 chr11:58668437-58668458
43	CTCF	chr11:58690820-58690970	GM12869	blood:	n/a	n/a
44	CTCF	chr11:58668400-58668550	GM12871	blood:	n/a	chr11:58668444-58668457 chr11:58668442-58668460 chr11:58668437-58668458
45	CTCF	chr11:58690780-58690930	GM12869	blood:	n/a	n/a
46	CTCF	chr11:58673509-58673709	LNCaP	prostate:	n/a	n/a
47	CTCF	chr11:58690800-58690950	GM12878	blood:	n/a	n/a
48	CTCF	chr11:58726080-58726230	AG10803	skin:	n/a	chr11:58726167-58726185 chr11:58726168-58726184 chr11:58726169-58726190 chr11:58726170-58726183 chr11:58726170-58726179
49	CTCF	chr11:58690760-58690910	GM12878	blood:	n/a	n/a
50	CTCF	chr11:58672960-58673110	NHDF-neo	bronchial:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:58724252-58724302	NB4	blood:	n/a
2	chr11:58673577-58673627	NB4	blood:	n/a
3	chr11:58724252-58724302	NB4	blood:	n/a
4	chr11:58673577-58673627	NB4	blood:	n/a
5	chr11:58673577-58673627	U87	brain:	n/a
6	chr11:58731104-58731154	PrEC	prostate:	n/a
7	chr11:58668977-58669027	NHBE	bronchial:	n/a
8	chr11:58668977-58669027	HRCEpiC	kidney:	n/a
9	chr11:58668488-58668538	H1-hESC	embryonic stem cell:	embryo
10	chr11:58673615-58673665	IMR90	lung:	fetal
11	chr11:58673167-58673217	HAEpiC	amniotic membrane:	n/a
12	chr11:58673453-58673503	AG04450	lung:	fetal
13	chr11:58710158-58710208	HPAEpiC	pulmonary alveolar:	n/a
14	chr11:58724252-58724302	AoSMC	blood vessel:	n/a
15	chr11:58668977-58669027	HUVEC	blood vessel:	n/a
16	chr11:58673167-58673217	HUVEC	blood vessel:	n/a
17	chr11:58695093-58695143	HNPCEpiC	eye:	n/a
18	chr11:58668345-58668395	HCF	heart:	n/a
19	chr11:58696069-58696119	AG10803	skin:	n/a
20	chr11:58694950-58695000	HIPEpiC	eye:	n/a
21	chr11:58673453-58673503	HUVEC	blood vessel:	n/a
22	chr11:58696069-58696119	ovcar-3	ovarian:	n/a
23	chr11:58673477-58673527	HCPEpiC	choroid plexus:	n/a
24	chr11:58672888-58672938	HCT-116	colon:	n/a
25	chr11:58695093-58695143	HCM	heart:	n/a
26	chr11:58694219-58694269	HCF	heart:	n/a
27	chr11:58728533-58728583	GM12878	blood:	n/a
28	chr11:58694950-58695000	AG09309	skin:	n/a
29	chr11:58668977-58669027	ProgFib	skin:	n/a
30	chr11:58694950-58695000	NH-A	brain:	n/a
31	chr11:58710266-58710316	AG09309	skin:	n/a
32	chr11:58731104-58731154	HEK293	kidney:	embryo
33	chr11:58694950-58695000	SK-N-MC	brain:	n/a
34	chr11:58695093-58695143	AG04450	lung:	fetal
35	chr11:58695093-58695143	AG10803	skin:	n/a
36	chr11:58724252-58724302	A549	lung:	n/a
37	chr11:58694950-58695000	SK-N-SH	brain:	n/a
38	chr11:58668977-58669027	HEEpiC	esophagus:	n/a
39	chr11:58724252-58724302	NHDF-neo	bronchial:	n/a
40	chr11:58673453-58673503	IMR90	lung:	fetal
41	chr11:58728533-58728583	ECC-1	luminal epithelium:	n/a
42	chr11:58731104-58731154	K562	blood:	n/a
43	chr11:58668488-58668538	SKMC	muscle:	n/a
44	chr11:58672888-58672938	HUVEC	blood vessel:	n/a
45	chr11:58673577-58673627	Jurkat	blood:	n/a
46	chr11:58694219-58694269	HCT-116	colon:	n/a
47	chr11:58696069-58696119	AG09309	skin:	n/a
48	chr11:58672888-58672938	Hepatocyte	liver:	n/a
49	chr11:58695093-58695143	HEK293	kidney:	embryo
50	chr11:58675749-58675799	HCM	heart:	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:58667985..58668808-chr11:58825960..58826578,4	MCF-7	breast:
2	chr11:58421165..58421796-chr11:58687413..58688096,2	MCF-7	breast:
3	chr11:58661995..58664743-chr11:58668611..58670936,2	K562	blood:
4	chr11:58678524..58679504-chr6:58777166..58777745,2	MCF-7	breast:
5	chr11:58668032..58668917-chr11:58825619..58826508,3	K562	blood:
6	chr11:58721468..58724070-chr11:58726713..58729457,3	K562	blood:
7	chr11:58669175..58672165-chr11:58677460..58679347,2	K562	blood:
8	chr11:58677524..58679024-chr6:58777164..58778728,2	K562	blood:
9	chr11:58678524..58679504-chr6:58776958..58777672,3	MCF-7	breast:
10	chr11:58726086..58726653-chr11:58902781..58903961,3	K562	blood:
11	chr11:58671775..58674615-chr11:58675003..58676520,2	K562	blood:
12	chr11:58729566..58731391-chr11:58732930..58735906,2	K562	blood:
13	chr11:58721468..58724070-chr11:58726713..58729457,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GLYATL1-3	chr11:58672343-58672709	NONHSAT021486
2	lnc-GLYATL2-1	chr11:58684488-58684757	ENSG00000255523.1
3	lnc-GLYATL1-2	chr11:58710760-58710795	NONHSAT021491
4	lnc-GLYATL2-2	chr11:58701116-58703171	ENSG00000255240.1
5	lnc-GLYATL1-2	chr11:58710789-58711139	NONHSAT021492
6	lnc-GLYATL1-2	chr11:58714519-58714734	NONHSAT021492
7	lnc-GLYATL2-1	chr11:58695790-58696162	ENSG00000255523.1
8	lnc-GLYATL1-2	chr11:58711016-58711139	NONHSAT021491
9	lnc-GLYATL2-2	chr11:58725690-58726293	ENSG00000255240.1
10	lnc-GLYATL2-2	chr11:58701116-58703171	NR_033853
11	lnc-GLYATL1-2	chr11:58714519-58714948	NONHSAT021491

Variant related genes	Relation type
ENSG00000224130	TF binding region
GLYATL2	TF binding region
ENSG00000255523	TF binding region
GLYATL1	TF binding region
ENSG00000224130	CpG island
GLYATL2	CpG island
ENSG00000255523	CpG island
GLYATL1	CpG island
ENSG00000255240	chromatin interactions
ENSG00000224130	chromatin interactions
ENSG00000254877	chromatin interactions
ENSG00000166840	chromatin interactions
ENSG00000156689	chromatin interactions

Extended variants
information (count: 2297 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:2297 , 50 per page) page: 1 2 3 4 5 6 7 ... 46

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146054955	chr11:58668370-58668371	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs200436855	chr11:58668373-58668374	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs369053394	chr11:58668374-58668375	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs112927155	chr11:58668376-58668377	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs35601198	chr11:58668377-58668378	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs5792140	chr11:58668379-58668380	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs542406971	chr11:58668388-58668389	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs375791461	chr11:58668427-58668428	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs79104182	chr11:58668491-58668492	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs528582458	chr11:58668508-58668509	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs550775662	chr11:58668561-58668562	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs2156349	chr11:58668565-58668566	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs555749325	chr11:58668578-58668579	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs533447237	chr11:58668616-58668617	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs551709858	chr11:58668641-58668642	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs2187267	chr11:58668683-58668684	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs534295524	chr11:58668685-58668686	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs549238932	chr11:58668686-58668687	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs547107381	chr11:58668726-58668727	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs369053038	chr11:58668732-58668733	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs116175053	chr11:58668733-58668734	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs556397482	chr11:58668761-58668762	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs140912222	chr11:58668767-58668768	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs146357069	chr11:58668772-58668773	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs147888234	chr11:58668780-58668781	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs546836883	chr11:58668821-58668822	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs77025522	chr11:58668897-58668898	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs76576639	chr11:58668910-58668911	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs575751444	chr11:58668935-58668936	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs544350233	chr11:58669018-58669019	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
31	rs141839100	chr11:58669057-58669058	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs545422640	chr11:58669074-58669075	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs191825498	chr11:58669095-58669096	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs184999460	chr11:58669129-58669130	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs549380696	chr11:58669181-58669182	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs567715441	chr11:58669191-58669192	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs113477549	chr11:58669235-58669236	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs549992015	chr11:58669236-58669237	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs948819	chr11:58669239-58669240	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs538904319	chr11:58669296-58669297	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs553818323	chr11:58669328-58669329	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs112439281	chr11:58669359-58669360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs377394291	chr11:58669372-58669373	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs565982670	chr11:58669412-58669413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs7939049	chr11:58669421-58669422	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs554143377	chr11:58669462-58669463	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs542316934	chr11:58669542-58669543	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs369104149	chr11:58669615-58669616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs150102664	chr11:58669700-58669701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs528089029	chr11:58669732-58669733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Esophageal cancer	21851588	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Autism	22495309	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:1065 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:58651000-58671200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr11:58659400-58671000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr11:58665000-58668800	Enhancers	Primary hematopoietic stem cells	blood
4	chr11:58665200-58671600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr11:58667400-58668400	Enhancers	NHDF-Ad	bronchial
6	chr11:58667400-58668600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
7	chr11:58667600-58668400	Active TSS	Brain Angular Gyrus	brain
8	chr11:58667600-58668400	Active TSS	Brain Inferior Temporal Lobe	brain
9	chr11:58667600-58668800	Active TSS	Fetal Brain Female	brain
10	chr11:58667800-58668400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr11:58667800-58668400	Active TSS	Brain Anterior Caudate	brain
12	chr11:58667800-58668400	Active TSS	Brain Substantia Nigra	brain
13	chr11:58667800-58668400	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
14	chr11:58667800-58668400	Enhancers	Thymus	Thymus
15	chr11:58667800-58668400	Active TSS	A549	lung
16	chr11:58667800-58668600	Active TSS	iPS-18 Cell Line	embryonic stem cell
17	chr11:58667800-58668600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr11:58667800-58668600	Enhancers	Fetal Muscle Trunk	muscle
19	chr11:58667800-58668800	Active TSS	ES-I3 Cell Line	embryonic stem cell
20	chr11:58667800-58668800	Active TSS	H1 Cell Line	embryonic stem cell
21	chr11:58667800-58668800	Active TSS	HUES48 Cell Line	embryonic stem cell
22	chr11:58667800-58669000	Active TSS	HUES6 Cell Line	embryonic stem cell
23	chr11:58668000-58668400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
24	chr11:58668000-58668400	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr11:58668000-58668400	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr11:58668000-58668400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr11:58668000-58668400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
28	chr11:58668000-58668400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr11:58668000-58668400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr11:58668000-58668400	Enhancers	Cortex derived primary cultured neurospheres	brain
31	chr11:58668000-58668400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr11:58668000-58668400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr11:58668000-58668400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr11:58668000-58668400	Flanking Active TSS	Liver	Liver
35	chr11:58668000-58668400	Active TSS	Brain Cingulate Gyrus	brain
36	chr11:58668000-58668400	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
37	chr11:58668000-58668400	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
38	chr11:58668000-58668400	Active TSS	Fetal Lung	lung
39	chr11:58668000-58668400	Flanking Active TSS	Pancreas	Pancrea
40	chr11:58668000-58668400	Flanking Active TSS	HMEC	breast
41	chr11:58668000-58668400	Flanking Active TSS	Osteobl	bone
42	chr11:58668000-58668600	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr11:58668000-58668600	Active TSS	Fetal Intestine Large	intestine
44	chr11:58668000-58668600	Active TSS	Fetal Kidney	kidney
45	chr11:58668000-58668600	Active TSS	NH-A	brain
46	chr11:58668000-58668800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr11:58668000-58668800	Active TSS	H9 Cell Line	embryonic stem cell
48	chr11:58668000-58668800	Active TSS	iPS-20b Cell Line	embryonic stem cell
49	chr11:58668000-58668800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
50	chr11:58668000-58668800	Enhancers	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links